Consensus recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment selection and Sequencing in CLL or SLL
JD Soumerai, JC Barrientos, IE Ahn… - Blood …, 2024 - ashpublications.org
Over the past decade, treatment recommendations for patients with chronic lymphocytic
leukemia or small lymphocytic lymphoma (CLL/SLL) have shifted from traditional …
leukemia or small lymphocytic lymphoma (CLL/SLL) have shifted from traditional …
[HTML][HTML] Chimeric Antigen Receptor-T Cells in the Modern Era of Chronic Lymphocytic Leukemia Treatment
A Hatashima, M Shadman, V Raghunathan - Cancers, 2025 - mdpi.com
Pathway inhibitors targeting Bruton tyrosine kinase (BTK) and B-cell lymphoma-2 (BCL-2)
have dramatically changed the treatment landscape for both treatment-naïve and …
have dramatically changed the treatment landscape for both treatment-naïve and …
Holding the therapy in CLLp53: mechanisms to achieve durable responses
R Cantera, T Fernández-Barge… - Anti-Cancer …, 2025 - journals.lww.com
Chronic lymphocytic leukemia (CLL) is a common leukemia, mainly affecting the elderly.
Originating in the bone marrow, CLL involves the accumulation of B lymphocytes and …
Originating in the bone marrow, CLL involves the accumulation of B lymphocytes and …
[HTML][HTML] Recent Advances in the Molecular Biology of Chronic Lymphocytic Leukemia: How to Define Prognosis and Guide Treatment
A Arcari, L Morello, E Borotti, E Ronda, A Rossi… - …, 2024 - pmc.ncbi.nlm.nih.gov
Simple Summary The therapeutic landscape of Chronic Lymphocytic Leukemia (CLL) has
dramatically changed in recent years, with a shift from chemoimmunotherapy towards many …
dramatically changed in recent years, with a shift from chemoimmunotherapy towards many …
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on …
T Chatzikonstantinou, L Scarfò, E Minga… - …, 2024 - Wiley Online Library
Novel small molecule inhibitors have revolutionized the treatment of chronic lymphocytic
leukemia (CLL). Indeed, BTK (BTKi) and BCL2 inhibitors (BCL2i) alone or in combination …
leukemia (CLL). Indeed, BTK (BTKi) and BCL2 inhibitors (BCL2i) alone or in combination …
[PDF][PDF] Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research …
E Minga, D Chamou, J Kotaskova… - 2024 - scientiasalut.gencat.cat
Novel small molecule inhibitors have revolutionized the treatment of chronic lymphocytic
leukemia (CLL). Indeed, BTK (BTKi) and BCL2 inhibitors (BCL2i) alone or in combination …
leukemia (CLL). Indeed, BTK (BTKi) and BCL2 inhibitors (BCL2i) alone or in combination …